Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
12.40
+0.38 (3.16%)
At close: May 16, 2025, 4:00 PM
12.33
-0.07 (-0.56%)
After-hours: May 16, 2025, 4:02 PM EDT

Inhibrx Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
216.52152.6277.92-
Cash & Short-Term Investments
216.52152.6277.92-
Cash Growth
--45.09%--
Accounts Receivable
0.210.40.780.24
Other Receivables
-0.02-0.01
Receivables
0.210.420.780.26
Inventory
1.8929.890.81
Prepaid Expenses
2.674.195.674.53
Other Current Assets
2.091.21.090.67
Total Current Assets
223.39160.4295.366.26
Property, Plant & Equipment
12.4513.549.377.22
Other Long-Term Assets
6.86.833.163.16
Total Assets
242.64180.77307.8916.65
Accounts Payable
17.5814.8933.769.45
Accrued Expenses
24.0924.2520.499.46
Current Portion of Leases
1.971.62.061.86
Total Current Liabilities
43.6440.7356.3120.77
Long-Term Debt
98.65-206.97-
Long-Term Leases
5.96.451.113.17
Total Liabilities
148.247.18264.3923.95
Common Stock
000.01-7.3
Additional Paid-In Capital
243.89239.72657.23-
Retained Earnings
-149.44-106.13-613.73-
Shareholders' Equity
94.44133.5843.5-7.3
Total Liabilities & Equity
242.64180.77307.8916.65
Total Debt
106.538.05210.145.03
Net Cash (Debt)
109.99144.5567.78-5.03
Net Cash Growth
-113.25%--
Net Cash Per Share
7.129.655.75-
Filing Date Shares Outstanding
14.4814.4811.78-
Total Common Shares Outstanding
14.4814.4811.78-
Working Capital
179.75119.67239.05-14.51
Book Value Per Share
6.529.233.69-
Tangible Book Value
94.44133.5843.5-7.3
Tangible Book Value Per Share
6.529.233.69-
Machinery
10.3110.319.027.55
Construction In Progress
0.02-3.59-
Leasehold Improvements
0.80.80.440.44
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q